To elucidate the specific contribution of CSNK2A1 to tumor growth, we conducted an in vivo knockdown experiment using LEG244 PDX model mice by employing lentivirus-mediated shRNA delivery targeting CSNK2A1 (Supplemental Figure 8E). The gene discussed is CSNK2A1; the disease is neoplasm.